GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biostax Corp (OTCPK:BTAX) » Definitions » 5-Day RSI

BTAX (Biostax) 5-Day RSI : 30.54 (As of Mar. 13, 2025)


View and export this data going back to . Start your Free Trial

What is Biostax 5-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 5-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

As of today (2025-03-13), Biostax's 5-Day RSI is 30.54.

The industry rank for Biostax's 5-Day RSI or its related term are showing as below:

BTAX's 5-Day RSI is ranked better than
66.38% of 1520 companies
in the Biotechnology industry
Industry Median: 38.75 vs BTAX: 30.54

Competitive Comparison of Biostax's 5-Day RSI

For the Biotechnology subindustry, Biostax's 5-Day RSI, along with its competitors' market caps and 5-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biostax's 5-Day RSI Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biostax's 5-Day RSI distribution charts can be found below:

* The bar in red indicates where Biostax's 5-Day RSI falls into.



Biostax  (OTCPK:BTAX) 5-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biostax  (OTCPK:BTAX) 5-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 5-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.


Biostax 5-Day RSI Related Terms

Thank you for viewing the detailed overview of Biostax's 5-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


Biostax Business Description

Traded in Other Exchanges
N/A
Address
2431 Aloma Avenue, Suite 124, Winter Park, FL, USA, 32792
Biostax Corp is a biotechnology company utilizing the Biostax Development Engine, is a developer and marketer of pharmaceutical, biotechnology and MedTech products that have a well-defined path to market. The company is focused on driving the development and commercialization of proprietary mechanisms to prevent, intercept and improve these diseases at affordable cost. It is a therapeutic and health tech agnostic, constantly seeking assets with low acquisition costs and high growth opportunities having significant clinical and commercial potential.
Executives
Glen A Farmer officer: Chief Financial Officer 20358 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
H. Louis Salomonsky Jr. Revocable Trust 10 percent owner 2431 ALOMA AVE, SUITE 124, WINTER PARK FL 32792
Henry Louis Salomonsky director, 10 percent owner 2431 ALOMA AVE, SUITE 124, WINTER PARK FL 32792
Kelly O'brien Wilson 10 percent owner, officer: COO and ICEO and IP 2431 ALOMA AVE, SUITE 124, WINTER PARK FL 32792
James Norman Curley other: Member of 10% owner group 410 DAHLIA AVE, CORONA DEL MAR CA 92625
Empower Insurance Corp Ltd other: Member of 10% owner group 1254 LEEWARD HIGHWAY, 4 CARIBBEAN PLACE, PROVIDENCIALES W7 TKCA1ZZ
Global Reverb Corp 10 percent owner, other: Member of 10% owner group 100 S EOLA DR, UNIT 1703, ORLANDO FL 32801
Paul Puskadi other: Member of 10% owner group 2020 TIGERTAIL BLVD, 7A, DANIA BEACH FL 33004
Deane Rhodes other: Member of 10% owner group 9200 HALSEY CIRCLE NE, TUSCALOOSA AL 35406
Roger Dale Bozarth other: Member of 10% owner group 9028 GREAT HERON CIR, ORLANDO FL 32836
Joel Yanowitz other: Member of 10% owner group 100 TAMAL PLZ, SUITE 106, CORTE MADERA CA 94925
Rogoff Family Trust Dtd other: Member of 10% owner group 20701 N SCOTTSDALE DR, ST 107-501, SCOTTSDALE AZ 85255
George Sasko other: Member of 10% owner group 515 WESTCHESTER DR, STE D, CAMPBELL CA 95008
Raster Investments, Inc other: Member of 10% owner group 2384 ORCHARD CREST BLVD, MANASQUAN NJ 08736
Robert Jackman Dailey other: Member of 10% owner group 401 FIRST STREET, LOS ALTOS CA 94022

Biostax Headlines

From GuruFocus